SaneVax, Inc.

Safe, Affordable, Necessary & Effective Vaccines and Vaccination Practices

Panel May Clear Cervical Cancer Vaccine Trials

By Leave a Comment

By:  Joe C. Mathew, New Delhi 28 September 2010 The three-member expert committee of the health ministry may give a clean chit to the agencies that conducted observational clinical trials on the safety and efficacy of cervical cancer vaccines marketed by global drug majors GlaxoSmithKline (GSK) and Merck in the country. The studies, independently initiated […]

[Continue reading...]

Gardasil Research Targets Girls from Vulnerable Communities

By 9 Comments

By:  N B Sarojini and Anjali Shenoi 12 September 2010 During July and August 2009, the Andhra Pradesh and Gujarat governments, in association with the Indian Council of Medical Research (ICMR) and the Program for Appropriate Technology in Health (PATH), launched what they described as a ‘demonstration project’ for vaccination against cer­vical cancer. Vaccines against […]

[Continue reading...]

RTI Act Not Applicable to HPV Vaccine

By Leave a Comment

By:  Arti Dhar, ‘The Hindu’ 09 August 2010 NEW DELHI: Information on the demonstration project and licensing of two vaccines to prevent cervical cancer has been exempted from public disclosure under Section 8 of the Right to Information Act, 2005. This is the reply received in response to an RTI application, submitted to the Union […]

[Continue reading...]

HPV vaccinations in India: Moral and ethical questions raised by health advocacy groups

By Leave a Comment

By:  Norma Erickson, Vaccines Examiner 08 April 2010 Yesterday, V.M. Katoch, Director-General of the Indian Council of Medical Research, called a halt to an HPV vaccination ‘project’ being conducted in two rural Indian states, Andhra Pradesh and Gujarat. This ‘project’ was conducted by PATH International, in collaboration with the ICMR and the two respective state […]

[Continue reading...]

A shot in the arm of vaccine research

By Leave a Comment

By:  Kim Capstick 25 November 2010 Viruses can cause illnesses that range in severity from minor irritations to potentially fatal diseases – and have even been linked to the causes of some cancers. Viral infections cause tremendous suffering worldwide, but can be effectively contained with the use of vaccines – which use genetic information from […]

[Continue reading...]

A Tale of Two Vaccines — Why Price Discounts for Developing Countries Show Limits

By Leave a Comment

By: Tido von Shoen-Angerer  24 November 2010  GlaxoSmithKline (GSK) was caught red-handed last week selling Synflorix, a vaccine that protects children from pneumococcal disease, for USD $150 in Uganda — European prices, in effect — when at the same time, the pharmaceutical company is withholding the same vaccine from an international subsidy that hopes to […]

[Continue reading...]

Grant launches cervical cancer-free Indiana iniative

By Leave a Comment

By:  Indiana University School of Medicine 02 December 2010 Indiana will join a multi-state program focused on cervical cancer prevention thanks to an unrestricted gift from GlaxoSmithKline Pharmaceuticals to the Indiana University School of Medicine, in partnership with the Kristen Forbes EVE Foundation. Cervical Cancer-Free America (CCFA) is an initiative designed to raise awareness, increase […]

[Continue reading...]

GSK, Binnopharm aim for Russia’s vaccine market

By Leave a Comment

By:  Tracy Staton 29 November 2010 GlaxoSmithKline has teamed up with another emerging markets partner. The drugmaker inked a deal with Russian vaccine firm JSC Binnopharm to make and sell several of its big vaccines in that country. It’s just the latest in a series of tie-ups in developing countries for GSK, which is pinning […]

[Continue reading...]

FDA Panel Votes to Approve Second HPV Vaccine

By Leave a Comment

Posted by:  admin in ‘Pharmacy Drugs’ 16 October 2010 WASHINGTON – An FDA advisory panel today voted to recommend approval of GlaxoSmithKline‘s Cervarix vaccine for use against the two strains of human papillomavirus (HPV) that cause 70% of cervical cancers. In a separate action, the Vaccines and Related Biologics Committee recommended that the agency okay […]

[Continue reading...]

Vaccine suspensions and drug disasters has made 2010 annus horribilis for GlaxoSmithKline

By Leave a Comment

By:  Christina England 07 September 2010 GlaxoSmithKline the drug giants, have spent the last few days trying to stay off the bottom of the FTSE 100, especially after the UK’s Medicines and Healthcare Products Regulatory Agency said that it’s diabetes treatment Avandia should be pulled from sale, over concerns that it can lead to heart […]

[Continue reading...]

GSK Vaccine Like Rotarix May Cause Fatal Bowel Problem

By Leave a Comment

By:  Dr. Mercola 16 October 2010 The Food and Drug Administration said preliminary results from a study in Mexico involving GlaxoSmithKline’s Rotarix vaccine suggest an increased risk of a serious bowel problem that could be fatal. A statement posted to the FDA’s website said the study showed an increased risk of intussusception in the 31-day […]

[Continue reading...]

GlaxoSmithKline Influences Experts to Boost HPV Sales

By Leave a Comment

By:  Christina England 15 November 2010 A few days ago, the Daily Express ran an article which stated that cancer expert Professor Peter Sasieni recommended phasing out smear tests in favour of HPV testing. The opening statement in Victoria Fletcher’s article ‘New Cancer Check To Phase Out Smear Tests’ (http://www.express.co.uk/posts/view/210613/New-cancer-check-to-phase-out-smear-tests)read : “SMEAR tests for cervical […]

[Continue reading...]

GlaxoSmithKline Drops the Price of Cervarix

By Leave a Comment

Source: PharmaLive 25 October 2010 Today, GlaxoSmithKline Inc. (Canada), announced its plan to reduce the cost of CERVARIX™ by 30%. The cost reduction is in response to recent research that demonstrates the relatively high price of cervical cancer vaccines, coupled with a low understanding of their protective benefits topped the list of reasons why the […]

[Continue reading...]

News

Videos

Contact